Aurinia Pharmaceuticals I... (AUPH)
Aurinia Pharmaceuticals Max Pain By Strike
AUPH trades at $12.27, 53.4% above the near-term max pain of $8 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($3-$10), reflecting growing call interest at higher strikes. Key magnetic zone at 8 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Aurinia Pharmaceuticals Max Pain By Expiry
Max pain for AUPH shows an upward trend from 3 to 10, suggesting bullish positioning in longer-dated options. The 93% spread signals divergent expectations across timeframes. Most levels below 12.27 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 8 | -4.27 (-34.77%) |
| Sep 19, 2025 | 8 | -4.27 (-34.77%) |
| Oct 17, 2025 | 9 | -3.27 (-26.62%) |
| Jan 16, 2026 | 7 | -5.27 (-42.93%) |
| Apr 17, 2026 | 3 | -9.27 (-75.54%) |
| Jan 15, 2027 | 10 | -2.27 (-18.47%) |